Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Haixingyuan Biotechnology is a marine biotechnology company focused on the research, development, and production of algae-based solutions for the animal feed and pet food industries. Headquartered in Qingdao, China, the company utilizes marine resources to create sustainable, antibiotic-free products that enhance animal health and nutrition. Its core offerings include seaweed meal, soya lecithin, squid liver paste, and various feed additives derived from algae and yeast. The company maintains a strong R&D focus through collaborations with institutions like the Ocean University of China and operates a large-scale manufacturing facility that serves both domestic and international markets. Qingdao Haixingyuan is recognized as a National High-tech Enterprise and is committed to promoting green breeding practices globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Haixingyuan Biotechnology.